Neurocrine Biosciences Inc $4,280,446 Alkermes Plc $27,604,395 Epizyme, Inc. $88,200 Acceleron Pharma Inc $5,809,375 Neurocrine Biosciences Inc $4,280,446 Alkermes Plc $27,604,395 Epizyme, Inc. $88,200 Acceleron Pharma Inc $5,809,375